Which RA medications are considered acceptable up to the third trimester to minimize fetal risk?

Which RA medications are considered acceptable up to the third trimester to minimize fetal risk?

• A. Hydroxychloroquine, glucocorticoids, and NSAIDs
• B. Methotrexate and Leflunomide
• C. TNF inhibitors only
• D. Aspirin and acetaminophen only

Answer: (A)

The key idea is balancing disease control with fetal safety during pregnancy. Hydroxychloroquine is widely considered safe for both mother and fetus and is often continued to keep rheumatoid arthritis well controlled without major fetal risk. Glucocorticoids can be used for flares when needed, at the lowest effective dose, because their maternal benefits usually outweigh potential fetal risks when used judiciously. NSAIDs can help with pain and inflammation, and they’re generally acceptable earlier in pregnancy, but they pose risks later in pregnancy (such as affecting the fetal heart and kidney and delaying closure of the ductus arteriosus), so they'd be avoided in the third trimester. Taken together, using hydroxychloroquine, glucocorticoids, and NSAIDs up to the start of the third trimester aligns with minimizing fetal risk while keeping the mother's RA under control. Methotrexate and leflunomide are known teratogens and are contraindicated in pregnancy, so they don’t fit. TNF inhibitors can be used in some cases but aren’t limited to them alone, and relying only on TNF inhibitors omits other safe, commonly used options. Aspirin and acetaminophen alone do not provide disease-modifying control for RA.

The key idea is balancing disease control with fetal safety during pregnancy. Hydroxychloroquine is widely considered safe for both mother and fetus and is often continued to keep rheumatoid arthritis well controlled without major fetal risk. Glucocorticoids can be used for flares when needed, at the lowest effective dose, because their maternal benefits usually outweigh potential fetal risks when used judiciously. NSAIDs can help with pain and inflammation, and they’re generally acceptable earlier in pregnancy, but they pose risks later in pregnancy (such as affecting the fetal heart and kidney and delaying closure of the ductus arteriosus), so they'd be avoided in the third trimester. Taken together, using hydroxychloroquine, glucocorticoids, and NSAIDs up to the start of the third trimester aligns with minimizing fetal risk while keeping the mother's RA under control.

Methotrexate and leflunomide are known teratogens and are contraindicated in pregnancy, so they don’t fit. TNF inhibitors can be used in some cases but aren’t limited to them alone, and relying only on TNF inhibitors omits other safe, commonly used options. Aspirin and acetaminophen alone do not provide disease-modifying control for RA.